Clinical trial
Treatment of Psoriasis Using Acitretin in HIV-Positive Patients
NCT00002143 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00002143 |
|---|---|
| Title | Treatment of Psoriasis Using Acitretin in HIV-Positive Patients |
| Official title | Treatment of Psoriasis Using Acitretin in HIV-Positive Patients |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Psoriasis |
| Intervention type | Drug |
| Interventions | Acitretin |
| Enrollment | 30 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: